PIVKA-II for Predicting Portal Vein Thrombosis in Hepatocellular Carcinoma

RecruitingOBSERVATIONAL

Enrollment

116

Participants

Timeline

Start Date

January 15, 2025

Primary Completion Date

December 15, 2025

Study Completion Date

December 31, 2025

Conditions

Hepato Cellular Carcinoma (HCC)Portal Vein Tumour Thrombosis

Interventions

DIAGNOSTIC_TEST

Prothrombin induced by vitamin K absence II (PIVKA-II)

Serum PIVKA-II level will be measured in HCC patients with and without PVTT.

Trial Locations (1)

RECRUITING

Tanta University Hospitals, Tanta

All Listed Sponsors

lead

Tanta University

OTHER